Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Characteristics and Treatment Patterns of Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Multi-Country, Non-Interventional, Disease Registry

NCT06651073 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06651073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06651073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Characteristics and Treatment Patterns of Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Multi-Country, Non-Interventional, Disease Registry
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
October 1, 2024
Completion date
April 28, 2028
Enrollment
350 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

transthyretin amyloid cardiopathy